Clinical Trial Update: Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of cariprazine (RGH-188) in acute exacerbation of schizophrenia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2019-06-12